Biotech

All Articles

A closer examine Fierce Biotech's Fierce 15

.Within this full week's episode of "The Top Pipe," our team are actually diving in to Fierce Biotec...

Lilly experiences period 2 failing of tau-targeting med

.The confetti is still flying coming from Eli Lilly's event commemorating the commendation of Alzhei...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant leadership hirings, shootings as ...

Lykos will inquire FDA to reexamine its own choice complying with rejection of MDMA treatment for post-traumatic stress disorder

.Complying with an inadequate showing for Lykos Rehabs' MDMA candidate for trauma at a current FDA a...

AN 2 one-halfs census, quits stage 3 test after information disappoint

.AN2 Therapies is reassessing its own organization in reaction to poor midphase records, promising t...

Merck pays $700M for bispecific, spying autoimmune opening and also odds to test Amgen in cancer cells

.Merck &amp Co. is spending $700 thousand upfront to challenge Amgen in a blood stream cancer cells ...

Gilead spends J&ampJ $320M to go out licensing package for seladelpar

.With Gilead Sciences almost an FDA decision for its own liver health condition medication seladelpa...

' All palms on deck' at Lilly as peers target weight problems market

.CEO David Ricks may observe the companies establishing tents at basecamp behind Eli Lilly in a try ...

Entero laying off personnel, abandoning office and also stopping R&ampD

.Bed mattress Liquidators has actually transformed Entero Therapies white as a sheet. The creditor b...

Exelixis drops ADC after deciding it is actually no match for Tivdak

.Exelixis is actually quiting on its own cells factor (TF)- targeting antibody-drug conjugate after ...